Literature DB >> 15209189

Clinical trials referral resource. Current clinical trials of 17-AG and 17-DMAG.

Percy S Ivy1, Mason Schoenfeldt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209189

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  5 in total

1.  Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption.

Authors:  Andreas Rascher; Zhihao Hu; Greg O Buchanan; Ralph Reid; C Richard Hutchinson
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

2.  Inhibition of neuroblastoma xenograft growth by Hsp90 inhibitors.

Authors:  Junghee Kang; Adeela Kamal; Francis J Burrows; B Mark Evers; Dai H Chung
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

3.  ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia.

Authors:  Januario E Castro; Carlos E Prada; Olivier Loria; Adeela Kamal; Liguang Chen; Francis J Burrows; Thomas J Kipps
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

4.  Hsp90 and Hsp40/Erdj3 are required for the expression and anti-apoptotic function of KSHV K1.

Authors:  K W Wen; B Damania
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

Review 5.  Regulation of Geldanamycin Biosynthesis by Cluster-Situated Transcription Factors and the Master Regulator PhoP.

Authors:  Juan F Martín; Angelina Ramos; Paloma Liras
Journal:  Antibiotics (Basel)       Date:  2019-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.